Low oxygen concentrations impair tissue development in tissue-engineered cardiovascular constructs

Tissue Engineering - Part A

Volumn 18, Issue 3-4, 2012, Pages 221-231

  Van Vlimmeren, Marijke A A ^a   Driessen Mol, Anita ^a   Oomens, Cees W J ^a   Van Den Broek, Marloes ^a   Stoop, Reinout ^b   Bouten, Carlijn V C ^a   Baaijens, Frank P T ^a  

^a EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; COLLAGEN; COMPUTER SIMULATION; OXYGEN; SCAFFOLDS (BIOLOGY); STIFFNESS;

CARDIOVASCULAR CONSTRUCTS; CARDIOVASCULAR TISSUE ENGINEERING; CARDIOVASCULAR TISSUES; COLLAGEN CONTENT; CONTROL CULTURES; ENVIRONMENTAL FACTORS; EXPOSURE-TIME; EXTRACELLULAR MATRICES; EXTRACELLULAR MATRIX PRODUCTION; HOMOGENEOUS TISSUES; IN-VITRO; LOW OXYGEN; MECHANICAL BEHAVIOR; OXYGEN CONCENTRATIONS; THEORETICAL MODELS; TISSUE DEVELOPMENT; TISSUE PROPERTIES; TISSUE QUALITY;

TISSUE;

GLUCOSE; LACTIC ACID DERIVATIVE; OXYGEN; PLOD2 PROTEIN, HUMAN; PROCOLLAGEN LYSINE 2 OXOGLUTARATE 5 DIOXYGENASE; TISSUE SCAFFOLD;

ARTICLE; BIOLOGICAL MODEL; BIOMECHANICS; CARDIOVASCULAR SYSTEM; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; METHODOLOGY; PH; TISSUE CULTURE TECHNIQUE; TISSUE ENGINEERING;

BIOMECHANICS; CARDIOVASCULAR SYSTEM; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; HYDROGEN-ION CONCENTRATION; LACTATES; MODELS, BIOLOGICAL; OXYGEN; PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE; TISSUE CULTURE TECHNIQUES; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84856289185     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0658     Document Type: Article

References (39)

1. Flanagan, T.C., Sachweh, J., Frese, J., Schnoering, H., Gronloh, N., Koch, S., Tolba, R., Schmitz-Rode, T., and Jockenhoevel, S. In vivo remodelling and structural characterisation of fibrinbased tissue-engineered heart valves in the adult sheep model. Tissue Eng Part A 15, 2965, 2009.
2. Mol, A., Smits, A.I., Bouten, C.V., and Baaijens, F.P. Tissue engineering of heart valves: advances and current challenges. Expert Rev Med Devices 6, 259, 2009.
3. Sacks, M.S., Schoen, F.J., and Mayer, J.E. Bioengineering challenges for heart valve tissue engineering. Ann Rev Biomed Eng 11, 289, 2009.
4. Tschoeke, B., Flanagan, T.C., Koch, S., Harwoko, M.S., Deichmann, T., Ella, V., Sachweh, J.S., Kellomaki, M., Gries, T., Schmitz-Rode, T., and Jockenhoevel, S. Tissue-engineered small-caliber vascular graft based on a novel biodegradable composite fibrin-polylactide scaffold. Tissue Eng Part A 15, 1909, 2009.
5. Stekelenburg, M., Rutten, M.C., Snoeckx, L.H., and Baaijens, F.P. Dynamic straining combined with fibrin gel cell seeding improves strength of tissue-engineered small-diameter vascular grafts. Tissue Eng Part A 15, 1081, 2009.
6. L'Heureux, N., Dusserre, N., Marini, A., Garrido, S., de la Fuente, L., and McAllister, T. Technology insight: the evolution of tissue-engineered vascular grafts-from research to clinical practice. Nat Clin Pract Cardiovasc Med 4, 389, 2007.
7. Pibarot, P., and Dumesnil, J.G. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation 119, 1034, 2009.
8. Hoerstrup, S.P., Sodian, R., Daebritz, S., Wang, J., Bacha, E.A., Martin, D.P., Moran, A.M., Guleserian, K.J., Sperling, J.S., Kaushal, S., Vacanti, J.P., Schoen, F.J., and Mayer, J.E., Jr. Functional living trileaflet heart valves grown in vitro. Circulation 102, III44, 2000.
9. Hoerstrup, S.P., Cummings Mrcs, I., Lachat, M., Schoen, F.J., Jenni, R., Leschka, S., Neuenschwander, S., Schmidt, D., Mol, A., Gunter, C., Gossi, M., Genoni, M., and Zund, G. Functional growth in tissue-engineered living, vascular grafts: follow-up at 100 weeks in a large animal model. Circulation 114, I159, 2006.
10. Balguid, A., Rubbens, M.P., Mol, A., Bank, R.A., Bogers, A.J., van Kats, J.P., de Mol, B.A., Baaijens, F.P., and Bouten, C.V. The role of collagen cross-links in biomechanical behavior of human aortic heart valve leaflets-relevance for tissue engineering. Tissue Eng 13, 1501, 2007.
11. Guyton, A.C., and Hall, J.E. Textbook of Medical Physiology. Philadelphia: W.B. Saunders Company, 2000.
12. Balguid, A., Mol, A., van Vlimmeren, M.A.A., Baaijens, F.P.T., and Bouten, C.V.C. Hypoxia induces near-native mechanical properties in engineered heart valve tissue. Circulation 119, 290, 2009.
13. van Vlimmeren, M.A.A., Driessen-Mol, A., Broek, M.v.d., Bouten, C.V.C., and Baaijens, F.P.T. Controlling matrix formation and cross-linking by hypoxia in cardiovascular tissue engineering. J Appl Physiol 109, 1483, 2010.
14. Oomens, C., Brekelmans, M., and Baaijens, F. Biomechanics: Concepts and Computation. Cambridge Texts in Biomedical Engineering, Cambridge, United Kingdom, 2009.
15. Morsiani, E., Brogli, M., Galavotti, D., Bellini, T., Ricci, D., Pazzi, P., and Puviani, A.C. Long-term expression of highly differentiated functions by isolated porcine hepatocytes perfused in a radial-flow bioreactor. Artif Organs 25, 740, 2001.
16. Radisic, M., Malda, J., Epping, E., Geng, W., Langer, R., and Vunjak-Novakovic, G. Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng 93, 332, 2006.
17. Wang, L., Wilshaw, S.P., Korossis, S., Fisher, J., Jin, Z., and Ingham, E. Factors influencing the oxygen consumption rate of aortic valve interstitial cells: application to tissue engineering. Tissue Eng Part C Methods 15, 355, 2009.
18. Casey, T.M., and Arthur, P.G. Hibernation in noncontracting mammalian cardiomyocytes. Circulation 102, 3124, 2000.
19. Mol, A., Rutten, M.C., Driessen, N.J., Bouten, C.V., Zund, G., Baaijens, F.P., and Hoerstrup, S.P. Autologous human tissue-engineered heart valves: prospects for systemic application. Circulation 114, I152, 2006.
20. Mol, A., Lieshout, M.I., Dam-de Veen, C.G., Neuenschwander, S., Hoerstrup, S.P., Baaijens, F., and Bouten, C.V. Fibrin as a cell carrier in cardiovascular tissue engineering applications. Biomaterials 26, 8, 2004.
21. Cesarone, C.F., Bolognesi, C., and Santi, L. Improved microfluorometric DNA determination in biological material using 33258 Hoechst. Anal Biochem 100, 188, 1979.
22. Dolezel, J., Bartos, J., Voglmayr, H., and Greilhuber, J. Nuclear DNA content and genome size of trout and human. Cytometry A 51, 127, 2003.
23. Farndale, R.W., Buttle, D.J., and Barrett, A.J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883, 173, 1986.
24. Bank, R.A., Jansen, E.J., Beekman, B., and te Koppele, J.M. Amino acid analysis by reverse-phase high-performance liquid chromatography: improved derivatization and detection conditions with 9-fluorenylmethyl chloroformate. Anal Biochem 240, 167, 1996.
25. Bank, R.A., Beekman, B., Verzijl, N., de Roos, J.A.D.M., Nico Sakkee, A., and TeKoppele, J.M. Sensitive fluorimetric quantitation of pyridinium and pentosidine crosslinks in biological samples in a single high-performance liquid chromatographic run. J Chromatogr B 703, 37, 1997.
26. Robins, S.P., Duncan, A., Wilson, N., and Evans, B.J. Standardization of pyridinium crosslinks, pyridinoline and deoxypyridinoline, for use as biochemical markers of collagen degradation. Clin Chem 42, 1621, 1996.
27. Bustin, S.A., Benes, V., Garson, J.A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M.W., Shipley, G.L., Vandesompele, J., and Wittwer, C.T. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55, 611, 2009.
28. Hellemans, J., Mortier, G., De Paepe, A., Speleman, F., and Vandesompele, J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8, R19, 2007.
29. Morley, M.E., Riches, K., Peers, C., and Porter, K.E. Hypoxic inhibition of human cardiac fibroblast invasion and MMP-2 activation may impair adaptive myocardial remodelling. Biochem Soc Trans 35, 905, 2007.
30. Riches, K., Morley, M.E., Turner, N.A., O'Regan, D.J., Ball, S.G., Peers, C., and Porter, K.E. Chronic hypoxia inhibits MMP-2 activation and cellular invasion in human cardiac myofibroblasts. J Mol Cell Cardiol 47, 391, 2009.
31. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., and Walter, P. Molecular biology of the cell. Garl Sci 2002.
32. Brown, D.A., MacLellan, W.R., Dunn, J.C., Wu, B.M., and Beygui, R.E. Hypoxic cell death is reduced by pH buffering in a model of engineered heart tissue. Artif Cells Blood Substit Immobil Biotechnol 36, 94, 2008.
33. Rotin, D., Robinson, B., and Tannock, I.F. influence of hypoxia and an acidic environment on the metabolism and viability of cultured cells: potential implications for cell death in tumors. Cancer Res 46, 2821, 1986.
34. Gawlitta, D., Oomens, C.W., Bader, D.L., Baaijens, F.P., and Bouten, C.V. Temporal differences in the influence of ischemic factors and deformation on the metabolism of engineered skeletal muscle. J Appl Physiol 103, 464, 2007.
35. Rensen, S.S., Doevendans, P.A., and van Eys, G.J. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J 15, 100, 2007.
36. Beamish, J.A., He, P., Kottke-Marchant, K., and Marchant, R.E. Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering. Tissue Eng Part B Rev 16, 467, 2010.
37. Modarressi, A., Pietramaggiori, G., Godbout, C., Vigato, E., Pittet, B., and Hinz, B. Hypoxia impairs skin myofibroblast differentiation and function. J Invest Dermatol 130, 2818, 2010.
38. Bailey, A.J., Paul, R.G., and Knott, L. Mechanisms of maturation and ageing of collagen. Mech Ageing Dev 106, 1, 1998.
39. Siddiqui, A., Galiano, R.D., Connors, D., Gruskin, E., Wu, L., and Mustoe, T.A. Differential effects of oxygen on human dermal fibroblasts: acute versus chronic hypoxia. Wound Repair Regen 4, 211, 1996.